Drug · DIN 02499525
PRIVA-RIZATRIPTAN
No: cancelled before it was sold
Authorized, then cancelled before it was ever sold in Canada.
Status Cancelled Pre Market since July 29, 2022.
- Drug Identification Number (DIN)
- 02499525
- Company (DIN owner)
- Pharmapar Inc.Varennes, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Rizatriptan N02CC04
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| RIZATRIPTAN (RIZATRIPTAN BENZOATE) | 10 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- May 27, 2020: NOC 23688Abbreviated New Drug Submission (ANDS) · Administrative: Licensing Agreement Between Two Companies
Other DINs named PRIVA-RIZATRIPTAN
- DIN 02499533 · Cancelled Pre Market